Abstract
ERCC1 (excision repair cross complementing‐group 1) is a mammalian endonuclease that incises the damaged strand of DNA during nucleotide excision repair and interstrand cross‐link repair. Ercc1−/Δ mice, carrying one null and one hypomorphic Ercc1 allele, have been widely used to study aging due to accelerated aging phenotypes in numerous organs and their shortened lifespan. Ercc1−/Δ mice display combined features of human progeroid and cancer‐prone syndromes. Although several studies report cellular senescence and apoptosis associated with the premature aging of Ercc1−/Δ mice, the link between these two processes and their physiological relevance in the phenotypes of Ercc1−/Δ mice are incompletely understood. Here, we show that ERCC1 depletion, both in cultured human fibroblasts and the skin of Ercc1−/Δ mice, initially induces cellular senescence and, importantly, increased expression of several SASP (senescence‐associated secretory phenotype) factors. Cellular senescence induced by ERCC1 deficiency was dependent on activity of the p53 tumor‐suppressor protein. In turn, TNFα secreted by senescent cells induced apoptosis, not only in neighboring ERCC1‐deficient nonsenescent cells, but also cell autonomously in the senescent cells themselves. In addition, expression of the stem cell markers p63 and Lgr6 was significantly decreased in Ercc1−/Δ mouse skin, where the apoptotic cells are localized, compared to age‐matched wild‐type skin, possibly due to the apoptosis of stem cells. These data suggest that ERCC1‐depleted cells become susceptible to apoptosis via TNFα secreted from neighboring senescent cells. We speculate that parts of the premature aging phenotypes and shortened health‐ or lifespan may be due to stem cell depletion through apoptosis promoted by senescent cells.
Highlights
The accumulation of DNA damage is thought to be a major driver of age-related degeneration and pathologies and is considered one of the hallmarks of aging (Hasty, Campisi, Hoeijmakers, van Steeg, & Vijg, 2003)
We found that ERCC1 deficiency in human fibroblasts induced cellular senescence, and apoptosis
Localization of the terminal differentiation marker, loricrin, was abnormal in the skin of Ercc1−/Δ mice at 18 weeks of age, indicating a disruption in normal skin structure, possibly due to depletion of stem cell populations (Figure 5d). These data indicate that ERCC1 deficiency in the mouse skin results in cellular senescence followed by apoptosis and suggest that stem cell depletion, likely through apoptosis, may be a major cause of the premature skin aging in Ercc1−/Δ mice
Summary
The accumulation of DNA damage is thought to be a major driver of age-related degeneration and pathologies and is considered one of the hallmarks of aging (Hasty, Campisi, Hoeijmakers, van Steeg, & Vijg, 2003). Apoptosis and its link to tissue atrophy and pathologies in the Ercc1−/Δ mice have been observed by other groups (Niedernhofer et al, 2006; Takayama et al, 2014) It is unclear whether and how these two distinct cell fates are linked in this DNA damage-driven, premature aging mouse model. Localization of the terminal differentiation marker, loricrin, was abnormal in the skin of Ercc1−/Δ mice at 18 weeks of age, indicating a disruption in normal skin structure, possibly due to depletion of stem cell populations (Figure 5d) These data indicate that ERCC1 deficiency in the mouse skin results in cellular senescence followed by apoptosis and suggest that stem cell depletion, likely through apoptosis, may be a major cause of the premature skin aging in Ercc1−/Δ mice
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.